Editorial: Immunology of Vitiligo
dc.contributor.author | Seneschal, Julien | |
dc.contributor.author | Harris, John E. | |
dc.contributor.author | Le Poole, I. Caroline | |
dc.contributor.author | Passeron, Thierry | |
dc.contributor.author | Speeckaert, Reinhart | |
dc.contributor.author | Boniface, Katia | |
dc.date | 2022-08-11T08:10:00.000 | |
dc.date.accessioned | 2022-08-23T16:52:02Z | |
dc.date.available | 2022-08-23T16:52:02Z | |
dc.date.issued | 2021-06-24 | |
dc.date.submitted | 2021-10-27 | |
dc.identifier.citation | <p>Seneschal J, Harris JE, Le Poole IC, Passeron T, Speeckaert R, Boniface K. Editorial: Immunology of Vitiligo. Front Immunol. 2021 Jun 24;12:711080. doi: 10.3389/fimmu.2021.711080. PMID: 34249018; PMCID: PMC8264751. <a href="https://doi.org/10.3389/fimmu.2021.711080">Link to article on publisher's site</a></p> | |
dc.identifier.issn | 1664-3224 (Linking) | |
dc.identifier.doi | 10.3389/fimmu.2021.711080 | |
dc.identifier.pmid | 34249018 | |
dc.identifier.uri | http://hdl.handle.net/20.500.14038/41975 | |
dc.description.abstract | Disappearance of melanocytes is the pathogenic hallmark of vitiligo. Progressive depigmentation of the skin has a high negative impact on patients’ quality of life. To date, vitiligo remains a therapeutic challenge. Several theories have been proposed to explain disease pathogenesis, considering the roles of increased inflammatory and cytotoxic immune responses, neuropeptides, microvascular anomalies, intrinsic abnormalities in melanocyte and keratinocyte adhesion, as well as oxidative stress. Over the past decades, clinical, basic, and translational research on patient samples as well as in vitro and in vivo models have tremendously improved our understanding of the pathophysiology of the disease and highlighted its complexity. Such progress is of utmost importance to identify appropriate therapeutic targets and treatments to halt progression of the disease and to induce repigmentation. “Immunology of vitiligo” is a collection of six review articles and four original articles focusing on complementary aspects of the immune pathways involved in vitiligo, from a pathophysiologic to a therapeutic perspective. | |
dc.language.iso | en_US | |
dc.relation | <p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=34249018&dopt=Abstract">Link to Article in PubMed</a></p> | |
dc.rights | Copyright © 2021 Seneschal, Harris, Le Poole, Passeron, Speeckaert and Boniface. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.subject | adaptive immunity | |
dc.subject | innate immunity | |
dc.subject | melanocytes | |
dc.subject | oxidative stress | |
dc.subject | tolerance | |
dc.subject | translational research | |
dc.subject | vitiligo | |
dc.subject | Dermatology | |
dc.subject | Immunity | |
dc.subject | Immunopathology | |
dc.subject | Medical Immunology | |
dc.subject | Skin and Connective Tissue Diseases | |
dc.title | Editorial: Immunology of Vitiligo | |
dc.type | Editorial | |
dc.source.journaltitle | Frontiers in immunology | |
dc.source.volume | 12 | |
dc.identifier.legacyfulltext | https://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=5812&context=oapubs&unstamped=1 | |
dc.identifier.legacycoverpage | https://escholarship.umassmed.edu/oapubs/4779 | |
dc.identifier.contextkey | 25625665 | |
refterms.dateFOA | 2022-08-23T16:52:03Z | |
html.description.abstract | <p><p id="x-x-__p3">Disappearance of melanocytes is the pathogenic hallmark of vitiligo. Progressive depigmentation of the skin has a high negative impact on patients’ quality of life. To date, vitiligo remains a therapeutic challenge. <p id="x-x-__p4">Several theories have been proposed to explain disease pathogenesis, considering the roles of increased inflammatory and cytotoxic immune responses, neuropeptides, microvascular anomalies, intrinsic abnormalities in melanocyte and keratinocyte adhesion, as well as oxidative stress. Over the past decades, clinical, basic, and translational research on patient samples as well as <em>in vitro</em> and <em>in vivo</em> models have tremendously improved our understanding of the pathophysiology of the disease and highlighted its complexity. Such progress is of utmost importance to identify appropriate therapeutic targets and treatments to halt progression of the disease and to induce repigmentation. “Immunology of vitiligo” is a collection of six review articles and four original articles focusing on complementary aspects of the immune pathways involved in vitiligo, from a pathophysiologic to a therapeutic perspective.</p> | |
dc.identifier.submissionpath | oapubs/4779 | |
dc.contributor.department | Department of Dermatology | |
dc.source.pages | 711080 |